Viking Global Investors Lp - Insider Trading & Ownership

Location
600 Washington Blvd., Floor 11, Stamford, CT
Summary
The estimated value of insider holdings of Viking Global Investors Lp is at least $1.33B dollars as of October 9, 2025. Viking Global Investors Lp is the 10%+ Owner of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $816M. Viking Global Investors Lp is the 10%+ Owner of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $133M. Viking Global Investors Lp is the 10%+ Owner of FIGS, Inc. and owns shares of FIGS, Inc. (FIGS) stock worth about $89.6M. Viking Global Investors Lp is the 10%+ Owner of Ginkgo Bioworks Holdings, Inc. and owns shares of Ginkgo Bioworks Holdings, Inc. (DNA) stock worth about $79.4M. Viking Global Investors Lp is the 10%+ Owner of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $78.2M. Viking Global Investors Lp is the 10%+ Owner of STANDARD BIOTOOLS INC. and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $53.2M. Viking Global Investors Lp is the 10%+ Owner of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $30.2M. Viking Global Investors Lp is the 10%+ Owner of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $20M. Viking Global Investors Lp is the 10%+ Owner of PROCEPT BioRobotics Corp and owns shares of PROCEPT BioRobotics Corp (PRCT) stock worth about $13.4M. Viking Global Investors Lp is the 10%+ Owner of Frazier Lifesciences Acquisition Corp and owns shares of Frazier Lifesciences Acquisition Corp stock worth about $12.2M. Viking Global Investors Lp is the 10%+ Owner of Inhibrx Biosciences, Inc. and owns shares of Inhibrx Biosciences, Inc. (INBX) stock worth about $3.32M.
Signature
/s/ Scott M. Hendler signing on behalf of O. Andreas Halvorsen (7)(8)
All Insider Reports
All Insider Reports

Ownership of Viking Global Investors Lp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. 10%+ Owner $816M -$261M -24.2% Jun 27, 2025
ROIV Roivant Sciences Ltd. 10%+ Owner $133M Jun 22, 2023
FIGS FIGS, Inc. 10%+ Owner $89.6M Sep 2, 2021
DNA, DNABW Ginkgo Bioworks Holdings, Inc. 10%+ Owner $79.4M Mar 2, 2022
FDMT 4D Molecular Therapeutics, Inc. 10%+ Owner $78.2M Jan 4, 2024
LAB STANDARD BIOTOOLS INC. 10%+ Owner $53.2M Mar 18, 2024
AMLX Amylyx Pharmaceuticals, Inc. 10%+ Owner $30.2M Sep 8, 2022
RLYB Rallybio Corp 10%+ Owner $20M Nov 15, 2022
PRCT PROCEPT BioRobotics Corp 10%+ Owner $13.4M Mar 18, 2022
FLAC Frazier Lifesciences Acquisition Corp 10%+ Owner $12.2M Nov 22, 2022
INBX Inhibrx Biosciences, Inc. 10%+ Owner $3.32M -$11.3M -77.3% Oct 7, 2025
APG APi Group Corp 10%+ Owner $0 Jun 17, 2024
INBX Inhibrx, Inc. 10%+ Owner $0 May 30, 2024
RYZB RayzeBio, Inc. 10%+ Owner $0 Feb 26, 2024
TIC, TICAW ACUREN CORP 10%+ Owner Feb 14, 2025

Insider Transactions Reported by Viking Global Investors Lp:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.